Awarded

Liraglutid 18 mg / 3 ml Injektionslösung im Fertigpen bei Diabetes Mellitus Typ 2 St

Name: Liraglutid 18 mg / 3 ml Injektionslösung im Fertigpen bei Diabetes Mellitus Typ 2 St
Creator: PBMG eG
Published: 2026-10-18
License: https://ted.europa.eu/en/simap/legal-notice

Original language: German

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: PBMG eG
Winners: Biocon Biologics Germany GmbH
Contract value: no value published
Bids received: 3
Published: 18 Oct 2026
Awarded: 18 Oct 2026
Contract start: 1 Jul 2027
Contract end: 30 Jun 2028stated
Sector: Medical equipment and pharmaceuticals
Region: Hamburg
Source: Original notice on TED (723129-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
Vincristin 4,47 mg, entspricht Vincristin sulfat 5,00 mg in 5 ml Lsg. Durchstechflaschen St a 5 ml	PBMG eG	ratiopharm GmbH	—	18 Oct 2026
Vincristin 0,89 mg, entspricht Vincristin sulfat 1,00 mg in 1 ml Lsg. Injektionslösung St	PBMG eG	ratiopharm GmbH	—	18 Oct 2026
Poly(styrol-co-divinylbenzol)sulfonsäure (92:8), Calciumsalz 14,9 g Pulver St a 15 g	PBMG eG	ratiopharm GmbH	—	18 Oct 2026
Lipegfilgrastim 6 mg in 0.6 ml Lsg. Fertigspritzen St	PBMG eG	ratiopharm GmbH	—	18 Oct 2026
Zoledronsäure 5 mg in 100 ml Lsg. Infusionslösung St	PBMG eG	ALIUD PHARMA GmbH	—	18 Oct 2026
Tadalafil 20 mg Filmtabletten PAH St	PBMG eG	ALIUD PHARMA GmbH	—	18 Oct 2026